Clinical Interpretation of Detection of IgM Anti-Brucella Antibody in the Absence of IgG and Vice Versa; a Diagnostic Challenge for Clinicians

Publications

Share / Export Citation / Email / Print / Text size:

Polish Journal of Microbiology

Polish Society of Microbiologists

Subject: Microbiology

GET ALERTS

ISSN: 1733-1331
eISSN: 2544-4646

DESCRIPTION

0
Reader(s)
0
Visit(s)

Comment(s)
0
Share(s)

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue / page

Related articles

VOLUME 68 , ISSUE 1 (Oct 2019) > List of articles

Clinical Interpretation of Detection of IgM Anti-Brucella Antibody in the Absence of IgG and Vice Versa; a Diagnostic Challenge for Clinicians

REEM AL JINDAN / NIDA SALEEM * / AAMIR SHAFI / SHEIKH MUHAMMAD AMJAD

Keywords : Brucella-specific IgG, Brucella-specific IgM, Brucellosis, ELISA for Brucella

Citation Information : Polish Journal of Microbiology. Volume 68, Issue 1, Pages 51-57, DOI: https://doi.org/10.21307/pjm-2019-006

License : (CC-BY-NC-ND 4.0)

Published Online: 27-March-2019

ARTICLE

ABSTRACT

Graphical ABSTRACT

Content not available Share

FIGURES & TABLES

REFERENCES

  1. Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9(7):833–845. doi:10.1586/eri.11.55
    [CROSSREF]
  2. Aranís JC, Oporto CJ, Espinoza M, Riedel KI, Pérez CC, García CP. [Usefulness of the determination of IgG and IgM antibodies by ELISA and immunocapture in a clinical series of human brucellosis] (in Spanish). Rev Chilena Infectol. 2008;25(2):116–121. doi:10.4067/S0716-10182008000200006
    [CROSSREF]
  3. Asaad AM, Alqahtani JM. Serological and molecular diagnosis of human brucellosis in Najran, Southwestern Saudi Arabia. J Infect Public Health. 2012;5(2):189–194. doi:10.1016/j.jiph.2012.02.001 Medline
    [CROSSREF]
  4. Binnicker MJ, Theel ES, Larsen SM, Patel R. A high percentage of serum samples that test reactive by enzyme immunoassay for anti-Brucella antibodies are not confirmed by the standard tube agglutination test. Clin Vaccine Immunol. 2012;19(8):1332–1334. doi:10.1128/CVI.00197-12 Medline
    [CROSSREF]
  5. Corbel MJ. Recent advances in the study of Brucella antigens and their serological cross-reactions. Vet Bull. 1985;55:927–942.
  6. Fadeel MA, Hoffmaster AR, Shi J, Pimentel G, Stoddard RA. Comparison of four commercial IgM and IgG ELISA kits for diagnosing brucellosis. J Med Microbiol. 2011;60(12):1767–1773. doi:10.1099/jmm.0.033381-0 Medline
    [CROSSREF]
  7. Geresu MA, Kassa GM. A Review on diagnostic methods of brucellosis. J. Veterinar. Sci. Techno. 2016;7(1):323.
  8. Gómez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Muñoz A, López C. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008;15(6):1031–1033. doi:10.1128/CVI.00424-07 Medline
    [CROSSREF]
  9. ISCII. Spanish national records of notifiable diseases [Internet]. (in Spanish). 2018. Madrid (Spain): Carlos III Health Institute; [cited 2018 Aug 27]. Available from http://www.isciii.es/ISCIII/es/contenidos/fd-servicios-cientifico-tecnicos/fd-vigilancias-alertas/fd-enfermedades/enfermedades-declaracion-obligatoria-series-temporales.shtml
  10. Mantecón MÁ, Gutiérrez P, Zarzosa MP, Dueñas AI, Solera J, Fernández-Lago L, Vizcaíno N, Almaraz A, Bratos MA, Torres AR, et al. Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and followup of human acute brucellosis. Diagn Microbiol Infect Dis. 2006;55(1):27–35. doi:10.1016/j.diagmicrobio.2005.11.003 Medline
    [CROSSREF]
  11. Mantur B, Parande A, Amarnath S, Patil G, Walvekar R, Desai A, Parande M, Shinde R, Chandrashekar M, Patil S. ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg. 2010;83(2):314–318. doi:10.4269/ajtmh.2010.09-0790 Medline
    [CROSSREF]
  12. Özdemir M, Feyzioğlu B, Kurtoğlu MG, Doğan M, Dağı HT, Yüksekkaya Ş, Keşli R, Baysal B. A comparison of immuncapture agglutination and ELISA methods in serological diagnosis of brucellosis. Int J Med Sci. 2011;8(5):428–432. doi:10.7150/ijms.8.428 Medline
    [CROSSREF]
  13. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91–99. doi:10.1016/S1473-3099(06)70382-6 Medline
    [CROSSREF]
  14. Poester FP, Nielsen K, Ernesto Samartino L, Ling Yu W. Diagnosis of Brucellosis. The Open Vet Sci J. 2010;4(1):46–60. doi:10.2174/1874318801004010046
    [CROSSREF]
  15. Sharma R, Chisnall C, Cooke RPD. Evaluation of in-house and commercial immunoassays for the sero-diagnosis of brucellosis in a non-endemic low prevalence population. J Infect. 2008;56(2):108–113. doi:10.1016/j.jinf.2007.10.010 Medline
    [CROSSREF]
  16. Varshochi M, Majidi J, Amini M, Ghabili K, Shoja MM. False positive seroreactivity to brucellosis in tuberculosis patients: a prevalence study. Int J Gen Med. 2011;4:207–210. Medline
    [CROSSREF]
  17. Welch RJ, Litwin CM. A comparison of Brucella IgG and IgM ELISA assays with agglutination methodology. J Clin Lab Anal. 2010;24(3):160–162. doi:10.1002/jcla.20382 Medline
    [CROSSREF]

EXTRA FILES

COMMENTS